{"entity":{"id":"seekin","kind":"company","name":"SeekIn","aka":[],"tldr":"A company with laboratories in Shenzhen and San Diego that makes low-cost multi-cancer blood tests from protein markers and shallow DNA sequencing.","summary":"SeekIn, founded in 2017 according to its website, with a San Diego contact address and research affiliations in Shenzhen, makes OncoSeek, an artificial intelligence test on seven protein tumour markers aimed at low- and middle-income countries, and SeekInCare, which adds shallow whole-genome sequencing of cell-free DNA. Its studies are published with Sun Yat-sen Memorial Hospital and Johns Hopkins collaborators.","asOf":"2026-10-29","links":[{"label":"Official website","url":"https://www.seekincancer.com/"}],"tags":[],"related":[],"cancers":[],"sections":["early-detection","diagnostics"],"technologies":["mced","liquid-biopsy","proteomics"],"targets":[],"drugs":["oncoseek","seekincare"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"San Diego, CA","country":"US","companyType":"diagnostics","website":"https://www.seekincancer.com/","founded":2017,"investors":[],"funding":[]},"route":"/companies/seekin/","neighbours":{"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"},{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"}],"technology":[{"id":"liquid-biopsy","kind":"technology","name":"Liquid biopsy (ctDNA)","route":"/technologies/liquid-biopsy/"},{"id":"mced","kind":"technology","name":"Multi-cancer early detection (MCED)","route":"/technologies/mced/"},{"id":"proteomics","kind":"technology","name":"Proteomics & phosphoproteomics","route":"/technologies/proteomics/"}],"drug":[{"id":"oncoseek","kind":"drug","name":"OncoSeek","route":"/drugs/oncoseek/"},{"id":"seekincare","kind":"drug","name":"SeekInCare","route":"/drugs/seekincare/"}],"paper":[{"id":"paper-oncoseek-npj-precis-oncol-2025","kind":"paper","name":"A large-scale, multi-centre validation study of an AI-empowered blood-based test for multi-cancer early detection","route":"/key-papers/paper-oncoseek-npj-precis-oncol-2025/"},{"id":"paper-oncoseek-eclinicalmedicine-2023","kind":"paper","name":"A panel of seven protein tumour markers for effective and affordable multi-cancer early detection by artificial intelligence: a large-scale and multicentre case-control study","route":"/key-papers/paper-oncoseek-eclinicalmedicine-2023/"},{"id":"paper-seekincare-j-mol-diagn-2025","kind":"paper","name":"Clinical Validation of a Noninvasive Multi-Omics Method for Multicancer Early Detection in Retrospective and Prospective Cohorts","route":"/key-papers/paper-seekincare-j-mol-diagn-2025/"}]}}